Proteoglycans synthesized by cultured bovine aortic smooth muscle cells after exposure to lead: Lead selectively inhibits the synthesis of versican, a large chondroitin sulfate proteoglycan

Toxicology

Volumn 154, Issue 1-3, 2000, Pages 9-19

  Fujiwara, Yasuyuki ^a   Yamamoto, Chika ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Lead; Proteoglycan; Vascular smooth muscle cell; Versican

Indexed keywords

2 DIETHYLAMINOETHANOL; CETYLPYRIDINIUM SALT; CHONDROITIN ABC LYASE; CORE PROTEIN; CYSTEINE; DERMATAN SULFATE; LEAD; LEAD NITRATE; METHIONINE; PAPAIN; PROTEOCHONDROITIN SULFATE; SEPHAROSE; SULFATE; VERSICAN;

ANIMAL CELL; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CATTLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; LEAD POISONING; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEOGLYCAN SYNTHESIS; REACTION ANALYSIS; SMOOTH MUSCLE FIBER; SURFACE CHARGE;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; CHONDROITIN ABC LYASE; CHROMATOGRAPHY, AGAROSE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; LEAD; LECTINS, C-TYPE; MUSCLE, SMOOTH, VASCULAR; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SULFUR RADIOISOTOPES; VERSICANS;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0034706905     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00269-9     Document Type: Article

References (59)

1. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis
2. Chemical changes in the arterial wall during regression of atherosclerosis in monkeys
3. Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity - A role in atherogenesis
4. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis
5. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta
6. A follow-up study of lead workers
7. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells
8. Transforming growth factor-beta inhibits endothelial cell proliferation
9. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: A lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis
10. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture
11. Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms
12. Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells
13. Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells
14. Analysis of developmentally homogeneous neural crest cell populations in vitro. IV. Cell proliferation and synthesis of glycosaminoglycans
15. Proteoglycans: Many forms and many functions
16. The biology of perlecan: The multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices
17. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans
18. Glycosaminoglycan: Molecular properties, protein interactions, and role in physiological processes
19. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture
20. Effect of lead on the glycosaminoglycans metabolism of bovine aortic endothelial cells in culture
21. Inhibitory effect of lead on the release of tissue plasminogen activator from human vascular endothelial cells in culture
22. Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells
23. Severe damage of cultured vascular endothelial cell monolayer after exposure to cadmium and lead
24. Lead-induced alteration of heparan sulfate proteoglycans in cultured vascular endothelial cells
25. 1 in cultured bovine aortic endothelial cells
26. A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Hyaluronate binding properties of versican
29. Aggrecan-versican-neurocan family proteoglycans
30. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells
31. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications
32. Atherosclerosis and hypertension induced by lead and cadmium ions: An effect prevented by calcium ion
33. Response to injury and atherogenesis
34. Proteoglycans as modulators of growth factor activities
35. Structure and biology of proteoglycans
36. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor beta 1
37. Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages
38. Autocrine activities of bovine basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis
39. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells
40. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells
41. Lead, blood pressure, and cardiovascular disease in men and women
42. The distribution of mesenchyme proteoglycan (PG-M) during wing bud outgrowth
43. Isolation of lipoprotein-acid mucopolysaccharide complexes from fatty streaks of human aortas
44. Elevated expression of proteoglycans in proliferating vascular smooth muscle cells
45. Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
46. A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells
47. Method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulfate
48. Vessel proteoglycans and thrombogenesis
49. Cell biology of arterial proteoglycans
50. The vascular extracellular matrix
51. The response-to-retention hypothesis of early atherogenesis
52. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican
53. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion
54. Effect of lead on the synthesis of tissue plasminogen activator by vascular endothelial cells in culture
55. Lead perturbs the regulation of spontaneous release of tissue plasminogen activator and plasminogen activator inhibitor-1 from vascular smooth muscle cells and fibroblasts in culture
56. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry
57. Glycosaminoglycans in normal and atherosclerotic human coronary arteries
58. Multiple domains of the large fibroblast proteoglycan, versican
59. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis